Mika Godts may have played his last match for Ajax on Thursday night. The Belgian has reached a personal agreement with Paris Saint-Germain and is now waiting for the clubs to negotiate. Captain Davy ...

A member of the loan army at La Liga champions Barcelona on Sunday got his latest stint away from Catalunya’s capital up and running in encouraging fashion.The player in question? Marc-André ter St ...

Ajax begin their efforts to qualify for the main stage of the Conference League with a second qualifying round tie against FK Vojvodina. While the Dutch giants earn entry to this phase of qualifying, ...

Are you tired of dealing with frustrating issues while streaming on OBS (Open Broadcaster Software)? Many users encounter the dreaded “encoding overloaded” message, which can be a real buzzkill during ...

Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first major public test, and the initial clinical data show why the pharma giant made the bet. The Ajax acquisition was a ...

Eli Lilly LLY0.48%increase; up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Eli Lilly & Co. agreed to buy closely held Ajax Therapeutics Inc. for as much as $2.3 billion in cash, part of its effort to build out a portfolio of breakthrough cancer therapies. Ajax’s lead ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

April 27 (Reuters) - Eli Lilly ⁠said ⁠on Monday it would ⁠buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ‌expand its oncology ...

Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker's blood-cancer portfolio. Eli Lilly on Monday said Ajax is ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, ...